Frazer A. Tessema
Researcher · Economics, Econometrics and Finance
Source-listed associations: Brigham and Women's Hospital; Harvard University; University of Chicago; University of Chicago Medical Center
United States
Frazer A. Tessema has indexed research in Economics, Econometrics and Finance. Research topics in the source record include Pharmaceutical Economics and Policy, Pharmaceutical industry and healthcare, Pharmaceutical studies and practices.
Read biography ↓Biography, research & contributions
Frazer A. Tessema has indexed research in Economics, Econometrics and Finance. Research topics in the source record include Pharmaceutical Economics and Policy, Pharmaceutical industry and healthcare, Pharmaceutical studies and practices.
Research and publications
The selected publications below appear in both the public ORCID record and the OpenAlex author record. The list is a subset of the researcher’s work.
Institutional record
OpenAlex lists Brigham and Women's Hospital; Harvard University; University of Chicago; University of Chicago Medical Center among its last-known institutional associations. These records do not confirm a current appointment.
Identity and source coverage
The public ORCID name and at least one education or employment institution were matched with the OpenAlex record on 2026-10-03. Publication identifiers were also compared between the two sources. Positions, education, honors and portrait are included only when separately documented.
At a glance
- Full name
- Frazer A. Tessema
- Alternative names
- Frazer A Tessema Frazer A. Tessema Frazer Tessema
- Fields
- Economics, Econometrics and Finance
- ORCID
- 0000-0001-9764-4205
- OpenAlex ID
- A5039427198
Research interests
- Pharmaceutical Economics and Policy
- Pharmaceutical industry and healthcare
- Pharmaceutical studies and practices
- Medication Adherence and Compliance
- Iron Metabolism and Disorders
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
- High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions ↗2023 · American Society of Clinical Oncology Educational BookDOI: 10.1200/edbk_397912
- Physicians’ Perspectives on FDA Approval Standards and Off-label Drug Marketing ↗2019 · JAMA Internal MedicineDOI: 10.1001/jamainternmed.2018.8121
- Public funding for transformative drugs: the case of sofosbuvir ↗2020 · Drug Discovery TodayDOI: 10.1016/j.drudis.2020.09.024
- Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs ↗2019 · JAMA Network OpenDOI: 10.1001/jamanetworkopen.2019.9570
- US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate ↗2020 · JAMA Internal MedicineDOI: 10.1001/jamainternmed.2020.2771
Citation & publication trends
Annual source counts; separate scales. OpenAlex coverage may be incomplete for historical researchers.
View exact annual counts
| Year | Publications | Citations |
|---|---|---|
| 2017 | 1 | 10 |
| 2018 | 1 | 8 |
| 2019 | 6 | 93 |
| 2020 | 5 | 62 |
| 2021 | 2 | 9 |
| 2022 | 3 | 18 |
| 2023 | 2 | 137 |
| 2024 | 2 | 25 |
| 2026 | 4 | 0 |
Source: OpenAlex · Retrieved 2026-10-03T06:38:08+00:00. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions ↗2023-06-01 · American Society of Clinical Oncology Educational Book133OpenAlex citations
- Physicians’ Perspectives on FDA Approval Standards and Off-label Drug Marketing ↗2019-01-24 · JAMA Internal Medicine27OpenAlex citations
- Public funding for transformative drugs: the case of sofosbuvir ↗2020-10-01 · Drug Discovery Today26OpenAlex citations
- 26OpenAlex citations
- US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate ↗2020-07-20 · JAMA Internal Medicine15OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Eisenmenger Syndrome Complicated by Hemorrhagic Hereditary Telangiectasia ↗2026-06-19 · JACC Case Reports
- Baroreflex Activation Therapy Invasive Hemodynamic “Reverse Ramp” Titration ↗2026-03-24 · Journal of the Society for Cardiovascular Angiography & Interventions
Journals published in
- Drug Discovery Today
- Drug Safety
- Health Affairs
- JAMA Internal Medicine
- JAMA Network Open
- Journal of General Internal Medicine
Related publishers
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: Pending review · Last data update: 2026-10-03T08:11:25+00:00
Automated identity and publication-source comparison: 2026-10-03T07:03:35+00:00. This is separate from manual editorial review and profile ownership.
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.